WSTN SEC filings, in plain English
Everything Westin has filed with the SEC that we hold — 37 filings, newest first, 34 with a plain-English summary of what changed and why it matters. Every row links to the primary document on EDGAR, so you can check the source rather than trust us.
The feed
live EDGAR captureNew filings appear here within minutes of hitting EDGAR; summaries follow once the pipeline has read them.
What changed: Current Report on Form 8-K filed as a Rule 425 communication, announcing the definitive Business Combination Agreement between Westin Acquisition Corp. (SPAC) and First Choice Healthcare Solutions, Inc., including full text of the BCA, Parent Support Agreement, Company Support Agreement, form of Lock-Up Agreement, form of Registration Rights Agreement, Share Transfer Agreement, and press release. Initial definitive deal announcement: (1) SPAC to domesticate from Cayman to Nevada and rename Wellgevity 360, Inc.; (2) target valued at up to ~$650 million equity value; (3) PIPE investment of up to $10,000,000 (stated value $12,500,000) contemplated but not yet committed; (4) trust account had at least $58,360,098 as of March 31, 2026; (5) closing deadline March 31, 2027, auto-extending to April 30, 2027 if S-4 not effective by Feb. 28, 2027; (6) sponsor change: Westin Ventures Holdings Ltd. transferred all Sponsor shares to EU Asia Holidays Pte. Ltd. for $1 plus other consideration, with ultimate controlling person changing from Kok Peng Na to Hanjie Ong; (7) Sponsor and certain other Parent shareholders entered into Parent Support Agreement agreeing not to redeem or transfer shares and to vote in favor; (8) target concurrently acquiring Pointe Med Entities substantially at closing; (9) post-closing board to consist of 5 directors (1 by Sponsor, 3 by Company, CEO); (10) lock-up period of 6 months for Sponsor and certain stockholders with potential early release at $18.00 for 30 days. Why it matters: This filing provides the full terms of the proposed business combination, including the trust value, redemption mechanics (public shareholders can redeem at the Redemption Price per the trust agreement), extension provisions, and sponsor conduct (including a change of control of the sponsor entity). Investors can now evaluate deal economics, the PIPE backstop (uncommitted as of filing), and governance. The sponsor support agreement reduces the risk of large redemptions by locking in insider votes and no-redemption commitments. The deadline gives a clear timeframe for the proxy vote and closing, and the automatic extension provides a contingency for SEC review. The sponsor change is a notable event that may affect investor confidence or regulatory scrutiny.
What changed: 8-K filed July 29, 2026, announcing a definitive Business Combination Agreement between Westin Acquisition Corp. (SPAC) and First Choice Healthcare Solutions, Inc., along with a sponsor share transfer that changed control of the sponsor. Westin entered into a Business Combination Agreement with First Choice Healthcare Solutions, valued at up to $650 million. Concurrently, the sponsor (Westin Investment Co. Ltd.) was sold by Westin Ventures Holdings Ltd. to EU Asia Holidays Pte. Ltd. for $1.00, resulting in Mr. Hanjie Ong becoming the ultimate controlling person of the sponsor. The sponsor continues to hold 2,012,500 Class B shares and 235,000 private placement units, representing ~27.9% of outstanding ordinary shares. The SPAC will domesticate to Nevada and rename to Wellgevity 360, Inc. A PIPE of up to $10 million (stated value $12.5M) is contemplated but not yet executed. The target also has binding agreements to acquire Pointe Med Entities concurrently with closing. Closing deadline is March 31, 2027 (auto-extend to April 30, 2027 if SEC effectiveness delayed). Why it matters: This is the definitive deal announcement for Westin, setting the terms for redemption: trust per share is $10.00, deadline extended to 2027, and a $650M valuation. The sponsor change may be relevant for assessing sponsor alignment and insider support. The target operates in the growing wellness and longevity healthcare market. No PIPE agreements signed yet, adding execution risk.
What changed: This filing IS a Schedule 13D/A beneficial ownership report appended with Exhibit 4: a Share Transfer Agreement dated July 25, 2026. Concerning SPAC mechanics, the filing records no adjustments to the redemption calendar, trust account valuations, extension votes, or the announced merger status. The attached agreement stipulates that Westin Ventures Holdings Ltd. conveys 100 percent of its outstanding equity to EU Asia Holidays Pte. Ltd. for US$1.00 and other good and valuable consideration. Completion is scheduled for the Effective Date of July 25, 2026, requiring delivery of share certificates and updating the register of members. Signatory Mr. Kok Peng Na executes for the Transferor, while signatory Mr. Hanjie Ong executes for the Transferee. The Transferor represents that it is the sole legal and beneficial owner, that the shares are fully paid, and that they carry no liens, charges, pledges, encumbrances, or third-party rights. Governing law is listed as the jurisdiction of incorporation (British Virgin Islands), and the Transferee’s Singapore registration number is cited as 201317245C. Why it matters: A total transfer of the holding company fundamentally alters the sponsor and control structure before the documented May 5, 2027 deadline, which directly impacts execution risk and shareholder redemption calculus. The document contains no substantiated claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel; those categories are entirely absent. Because the exhibit omits any reference to the trust per-share balance, no assumption that trusts are fixed at $10.00 can be drawn from this filing, and I note explicitly that trusts are not always $10.00. The substantive takeaway rests on the representational language and the absolute nature of the block transfer, which signals a pivot in corporate control without yet disclosing integration steps, financing arrangements, or target business metrics. Materiality is high given the control shift, though near-term transparency remains limited until successor filings address the merger timeline and capital deployment.
What changed: A Schedule 13G beneficial ownership report identifying Wolverine Asset Management, LLC, Wolverine Holdings, LLC, Christopher L. Gust, and Robert R. Bellick as the reporting holders for WSTN. The filing registers these four entities and individuals as crossing regulatory disclosure thresholds for WSTN shares. The submitted text contains no percentages, acquisition dates, share quantities, purchase prices, or dollar values. Accordingly, the filing discloses nothing regarding redemption deadlines, trust account balances, extension mechanisms, business combination milestones, or sponsor conduct. Why it matters: Under Securities and Exchange Commission rules, a Schedule 13G indicates that the named parties have attained beneficial ownership sufficient to warrant public reporting without a controlling purpose. Because the excerpt omits the exact stake acquired, the transaction date, and any voting or disposition agreements, the report provides no verifiable evidence of fresh capital entering the SPAC, supplemental private placement commitments, or shifts in merger pathway execution. Investors monitoring liquidity windows, trust preservation, or sponsor accountability will find no actionable mechanics in this snippet; the filing merely logs these holders’ statutory disclosures pending review of the complete exhibit for percentage figures, execution dates, and any attached statements regarding plan or purpose.
What changed: Quarterly report on Form 10-Q for the period ended March 31, 2026 — a standard periodic filing for a blank-check SPAC that completed its IPO in November 2025. First periodic report since the IPO closing. The trust account holds $58,360,098 against $57,500,000 of gross proceeds; trust-per-share ratio stands at roughly $10.15 (including earnings). Working capital outside trust is negative $149,751. The company reports a material weakness in disclosure controls and procedures related to identifying and disclosing commitment and contingencies agreements. No business combination target has been selected, and no substantive discussions have been initiated with any target. Why it matters: The disclosure control deficiency flags a potential risk that the sponsor has not been timely disclosing all agreements (e.g., letter-of-intent or earnout terms) that could affect redemption decisions. The negative working capital and going-concern disclosure underscore tight liquidity before the May 5, 2027 deadline. Trust value of $58.4M exceeds the $10.00 trust floor ($57.5M), providing a small buffer for redemption.
trust account, combination deadline, going-concern doubt +2nothing moved · 5 with no prior record of ours
- Trust account
- $57.5M · unchanged
- Combination deadline
- 2027-05-05 · unchanged
- Going-concern doubt
- stated · unchanged
- Sponsor loans outstanding
- $449K · unchanged
- Redeemable shares
- 5.00M · unchanged
The clause “288,371 ) Cash Flows from Investing Activity Purchase of marketable securities held in Trust Account ( 57,500,000 ) Net cash used in investing activity ( 57,500,000 ) Cash Flows from Financing Activities Proceeds from sale of public”…
The clause …“of an initial Business Combination. In addition, the Company currently has until May 5, 2027 (unless the Company extends such period by amending its Amended and Restated Memorandum and Articles of Association) to consummate the”…
The clause “014-15, Disclosures of Uncertainties about an Entity s Ability to Continue as a Going Concern, management has determined that the mandatory liquidation, should a business combination not occur, and potential subsequent dissolution, raises”…
The clause …“promissory note loans provided by the Sponsor. As of March 31, 2026, $449,377 was outstanding under the promissory note. 18 The Company has incurred and expects to continue to incur significant costs in pursuit of the”…
The clause “475 Class A ordinary shares, $ 0.0001 par value, 450,000,000 shares authorized, 5,000,000 shares subject to possible redemption as of March 31, 2026 51,743,085 - Commitment and contingencies (Note 6) Shareholders Equity Class A ordinary”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: A Schedule 13G/A amendment, which is a SEC beneficial ownership report submitted by KARPUS MANAGEMENT, INC. The provided text identifies only the filing type, the SEC docket identifier [0001072613-26-000438], the filing date of 2026-05-14, and the reporting holder KARPUS MANAGEMENT, INC. No alterations to share counts, percentage stakes, redemption instructions, trust account mechanics, extension votes, or sponsor conduct are detailed in the excerpt. Why it matters: Investors monitoring WSTN’s deal progress, redemption window, or potential trust liquidation should note that this excerpt contains no substantive updates to capital structure or timeline mechanics. Attributed solely to KARPUS MANAGEMENT, INC., the document functions as a periodic ownership disclosure rather than a transactional or governance filing. Full review of the amended schedule is necessary to determine whether the holder modified its position or declared investment purpose after the announced combination.
What changed: Schedule 13G, a routine compliance exhibit and SEC beneficial ownership reporting form. The filing attributes the reporting obligation to KARPUS MANAGEMENT, INC. and discloses no altered share counts, transaction dates, or statements regarding the announced deal timeline, the trust value per share, the redemption deadline, or sponsor conduct. Why it matters: As a standard institutional ownership report, the document does not mechanically alter redemption windows, trigger extensions, confirm partner alignment, or validate sponsor execution. Because the excerpt lacks schedule portions detailing aggregate holdings or investment purpose, the filing conveys no new substance regarding business combinations, customer claims, revenue metrics, market sizing, strategic pivots, technological developments, partnership structures, litigation posture, or personnel changes.
What changed: Schedule 13G beneficial ownership report. This filing lists Shaolin Capital Management LLC and David Puritz as reporting holders, but the provided excerpt contains no share quantities, ownership percentages, acquisition dates, or transaction purposes. Consequently, there is no disclosed movement impacting the May 5, 2027 redemption deadline, the trust balance, extension mechanisms, business combination progress, or sponsor conduct. Why it matters: Beneficial ownership filings map institutional and insider positioning ahead of SPAC lifecycle events. Tracking these entities establishes a baseline for monitoring cumulative stake changes that could influence voting alignment, redemption trends, or support for an extension around the 2027 deadline. The excerpt contains no operational, financial, or strategic assertions regarding customers, revenue, market size, technology, partnerships, litigation, or personnel; therefore, no other substantive claims require attribution or verification.
What changed: Quarterly report on Form 10-Q filed by Westin Acquisition Corp., a blank-check company, for the quarter and six months ended December 31, 2025. The filing reports the financial results for the period since the company's June 3, 2025 inception, including its November 5, 2025 IPO. It shows the company has no operations or revenue, and had a net income of $128,860 for the quarter attributable to interest income on its trust account, offset by formation and administrative costs. The company also reported a working capital deficit of $62,156 and disclosed that its disclosure controls and procedures were ineffective due to a lack of adequate controls to identify and timely disclose all agreements requiring disclosure for commitments and contingencies. Why it matters: The filing provides the first snapshot of the SPAC's post-IPO financial position and confirms it remains early in its lifecycle with no target selected. The disclosed going concern uncertainty and material weakness in internal controls are important operational red flags. The trust account holds $57.89 million, with $10.00 per public share initially anticipated for redemption, and the company has a business combination deadline of May 5, 2027.
trust account, redeemable shares, combination deadline +2nothing moved · 5 with no prior record of ours
- Trust account
- not previously extracted$57.5M
- Redeemable shares
- not previously extracted5.00M
- Combination deadline
- 2027-05-05 · unchanged
- Going-concern doubt
- stated · unchanged
- Sponsor loans outstanding
- $449K · unchanged
The clause “217,828 ) Cash Flows from Investing Activity Purchase of marketable securities held in Trust Account ( 57,500,000 ) Net cash used in investing activity ( 57,500,000 ) Cash Flows from Financing Activities Proceeds from sale of public”…
The clause “475 Class A ordinary shares, $ 0.0001 par value, 450,000,000 shares authorized, 5,000,000 shares subject to possible redemption as of December 31, 2025 50,431,383 - Commitment and contingencies (Note 6) Shareholders Equity Class A”…
The clause …“of an initial Business Combination. In addition, the Company currently has until May 5, 2027 (unless the Company extends such period by amending its Amended and Restated Memorandum and Articles of Association) to consummate the”…
The clause “014-15, Disclosures of Uncertainties about an Entity s Ability to Continue as a Going Concern, management has determined that the mandatory liquidation, should a business combination not occur, and potential subsequent dissolution, raises”…
The clause …“promissory note loans provided by the Sponsor. As of December 31, 2025, $449,377 was outstanding under the promissory note. 19 The Company has incurred and expects to continue to incur significant costs in pursuit of the”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: A joint filing agreement attached to a Schedule 13G/A regarding Class A ordinary shares of Westin Acquisition Corp. Feis Equities LLC and Lawrence M. Feis executed this routine compliance exhibit to formally authorize joint filings under Rule 13d-1(k) for their beneficial ownership statements. This procedural step does not modify WSTN’s trust mechanics, redemption timeline, extension provisions, merger progress, or sponsor conduct. The document contains zero substantive claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. Why it matters: Because this is purely a disclosure coordination exhibit, it has no direct impact on shareholder redemption decisions, trust valuations, deal completion risk, or sponsor accountability. Investors should examine the parent Schedule 13G/A filing (dated February 3, 2026) for actual changes in reported share counts or investment intent, as this attachment merely satisfies the Securities Exchange Act of 1934’s formatting rules for co-held positions.
What changed: This document IS a Form 8-K Current Report and an attached press release (Exhibit 99.1) issued by Westin Acquisition Corp. Per Item 8.01 of the 8-K, Westin Acquisition Corp updated a prior December 23, 2025 disclosure to state that holders of the company’s units may elect to separately trade the Class A ordinary shares and rights included in those units commencing December 31, 2025. According to the attached press release, the company originally sold 5,750,000 units in its initial public offering, which will now bifurcate into Class A ordinary shares trading under ‘WSTN’ and rights trading under ‘WSTNR,’ while unseparated units will continue under ‘WSTNU.’ The filing instructs holders to have their brokers contact Odyssey Stock Transfer & Trust Company, the named transfer agent, to execute the separation. For investors tracking redemption deadlines, trust value, extensions, deal progress, or sponsor conduct, the filing reports zero amendments or disclosures affecting those mechanics. The registrant made no statements regarding a business combination target, merger agreement terms, trust account per-share value, redemption thresholds, extension proposals, or sponsor compensation and litigation history. Why it matters: The administrative division of 5,750,000 pre-IPO units into separate equity and fractional-right instruments alters broker settlement workflows and secondary market optionality but does not modify fundamental shell protections or liquidation waterfalls. As Westin Acquisition Corp described the entity in Exhibit 99.1, it is a Cayman Islands exempted blank check company formed to effect a merger, share exchange, asset acquisition, share purchase, or reorganization with one or more businesses without limitation to a particular industry or geographic region. Chief Executive Officer and Chairman Kok Peng Na signed the 8-K, and Chief Financial Officer Stanney P. Majawit is listed as the media contact. Because the submission contains no operational metrics, revenue assumptions, customer disclosures, strategic partnerships, technology roadmaps, litigation summaries, or personnel changes beyond the signatories, its substantive impact is limited to confirming the revised separate-trading calendar. Investors must await subsequent regulatory submissions—such as definitive proxy statements, merger agreement exhibits, or Rule 425 written communications—that would quantify target valuation, anchor commitments, dilution schedules, and actual de-SPAC execution before trust deployment or redeemable interest calculations become operative.
What changed: Form 8-K current report and attached press release (Exhibit 99.1) announcing the election to separately trade Class A ordinary shares and fractional rights following the company’s initial public offering, accompanied by standard XBRL instance and schema files. According to the press release attached as Exhibit 99.1, the company announced that holders of the 5,750,000 units sold in the initial public offering may elect to separately trade the underlying Class A ordinary shares (trading symbol WSTN) and fractional rights entitling holders to receive one-sixth (1/6) of one Class A ordinary share (trading symbol WSTNR), commencing on December 23, 2025. Unseparated units will continue trading under WSTNU. The press release instructs holders to direct their brokers to contact Odyssey Stock Transfer & Trust Company to execute the separation. The filing does not report any modifications to the redemption calendar, trust account composition or per-share value, extension voting procedures, target selection updates, or sponsor compensation arrangements. Both the ordinary shares and the rights carry a par value of $0.0001. Why it matters: Investors tracking redemption mechanics should note this document contains no amended proxy statements, no notice of a special meeting, and no adjustments to the contractual deadline or trust distribution waterfalls; consequently, the procedures for invoking cash redemptions remain unchanged. Per the press release, Westin Acquisition Corp continues to operate as a blank check company structured to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination, with a stated approach that will not be limited to a particular industry or geographic region. Administrative unit separation typically precedes definitive merger agreements and allows secondary markets to price the equity and rights components independently, which shapes shareholder evaluation once management presents a specific business combination valuation and redemption framework. The filing was executed on behalf of the registrant by Chief Executive Officer and Chairman Kok Peng Na, and designates Chief Financial Officer Stanney P. Majawit as the investor contact. Because the submission adjusts trading conventions rather than altering capital commitments, liquidation priority, or fiduciary obligations, it functions as a structural liquidity update rather than a substantive deal milestone.
What changed: This document is a Schedule 13D filing, formally classified as a beneficial ownership report filed to disclose acquisitions of equity securities that cross regulatory reporting thresholds. The provided filing excerpt contains only the caption line and a system notation stating 'Structured holder table not present in this XML variant.' No reporting person, share quantity, acquisition date, purchase price, or stated purpose of transaction is displayed. Consequently, no modifications to the WSTN redemption deadline of 2027-05-05, the stated $10 per share trust value, extension provisions, announced merger progress, or sponsor conduct are recorded in this submission. Why it matters: A Schedule 13D indicates that an investor or related group has accumulated enough WSTN shares to trigger mandatory public disclosure, a milestone that frequently precedes votes on a business combination, proxy solicitations, or coordinated redemption pacing. Because the tabular data and cover page are missing from this extract, redemption-trackers cannot determine whether the newly positioned capital plans to exit prior to the 2027-05-05 deadline at the $10 per share trust level, or whether the stake reflects backing for the declared deal. No customer references, revenue estimates, market size projections, technology roadmap details, partnership announcements, litigation updates, or executive appointments appear in the text, meaning no chief executive, sponsor official, or target representative is attributed with strategic or operational claims in this filing. Full mechanical and commercial assessment requires locating the complete XML package or attached Exhibit A to reveal the identity of the reporting person, the exact block size, and the transaction purpose.
What changed: SEC Form 3 (Statement of Beneficial Ownership of Securities) filed as a routine insider ownership report for Westin Acquisition Corp. The filing states that Na Kok Peng, identified as director, Chairman and CEO, holds 2,232,500 shares indirectly. It discloses no modifications to redemption mechanics, trust account balances, extension voting windows, announced merger closings, or sponsor compensation structures. Why it matters: According to the filing, the reported indirect position of 2,232,500 shares provides a transparent baseline for management alignment ahead of the 2027-05-05 deadline. For investors monitoring SPAC execution, this confirms leadership capital commitment but introduces no forward-looking statements regarding target customers, revenue streams, market size, technology roadmaps, strategic partnerships, personnel changes, or pending litigation. The document serves as a statutory transparency snapshot with no impact on near-term redemption calendars or trust disbursement schedules.
What changed: Routine compliance exhibit: SEC Form 3 insider ownership report [0001213900-25-120164]. The filing discloses no non-derivative transactions or holdings reported by director Chung Adrian Xinglun for Westin Acquisition Corp as of 2025-12-10. This leaves insider share counts static and carries no impact on the redemption calendar, extension triggers, or deal progress metrics tied to the 2027-05-05 deadline or trust/share $10. Why it matters: The reporting person’s Form 3 establishes a regulatory baseline for insider equity under Section 16. Because the filer explicitly states zero transactions or holdings were reported, there are no insider purchases, sales, or option exercises to factor into sponsor conduct analysis or redemption pressure models. The document contains no substantive business updates: it makes no claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel beyond identifying the director. Investors should treat this as a procedural checkpoint rather than a signal of deal acceleration or terminal cash preservation.
What changed: SEC Form 3, an insider ownership report filed on 2025-12-10 for Westin Acquisition Corp. The filing discloses that CFO Majawit Stanney Patrick holds no non-derivative transactions or holdings to report. It does not modify the announced deal status, the 2027-05-05 redemption deadline, the $10 trust per share baseline, or sponsor conduct. No equity purchases, sales, options exercises, or convertible security conversions are recorded for the reporting period. Why it matters: Investors tracking pre-combination insider positioning find no actionable signals regarding redemption behavior or capital calls, as the form expressly states zero reported activity. Because the filing contains no commercial metrics, customer claims, technology disclosures, partnership announcements, or litigation details, it carries no near-term impact on valuation mechanics or extension voting timelines. Continued reliance on subsequent insider filings will be necessary to assess whether management adjusts positions ahead of the 2027-05-05 deadline.
What changed: A routine compliance exhibit: an SEC Form 3 initial beneficial ownership report filed by director Richard Keng Chong Lim for Westin Acquisition Corp. According to the SEC filing, the reporting director disclosed zero non-derivative transactions, sales, or equity holdings. This produces no adjustment to the redemption deadline (2027-05-05), no change to the trust account value or per-share allocations, no filing indicating an extension, no update on the announced merger's status, and no new data point regarding sponsor conduct or insider capital deployment. Why it matters: The document contains no substantive claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. Because the filing reports no insider stock activity, investors monitoring whether directors are committing personal capital ahead of the 2027-05-05 expiration window or before deal completion receive no directional signal. The exhibit serves strictly as an administrative baseline for regulatory ownership tracking and does not alter any mechanics governing redemptions, trust administration, or business combination execution.
What changed: A Form 3 insider ownership report, classified as a routine compliance exhibit for Westin Acquisition Corp. The filing states that Westin Investment Co. Ltd., identified as a 10% owner, directly holds 2,232,500 shares. It contains no updates, amendments, or disclosures related to the redemption deadline, trust value per share, extension timeline, or deal progress. The document contains no claims, projections, or data regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. Why it matters: This routine SEC filing confirms the registered direct shareholding of the 10% owner at the time of submission. For investors tracking WSTN mechanics, it establishes a baseline for sponsor-related equity concentration while leaving the existing redemption calendar unchanged. It introduces no new provisions affecting shareholder redemption rights, trust distribution timing, or warrant conversion structures.
What changed: SEC Form 3 initial beneficial ownership statement filed on 2025-12-10 by director Abdul Kadir Nakoorsha Bin for issuer Westin Acquisition Corp, explicitly stating that no non-derivative transactions or holdings were reported. Nothing altered in SPAC mechanics. The filing confirms zero insider stock movement, which does not impact the redemption deadline of 2027-05-05, the stated trust value of $10 per share, extension provisions, merger negotiations, or sponsor conduct. All calendar and valuation parameters remain unchanged from prior disclosures. Why it matters: This is a routine compliance exhibit requiring no strategic or redemption analysis. It contains no claims about customers, revenue, market size, technology, partnerships, litigation, or personnel. Because the filing attributes no transactions or holdings to the director, it provides no actionable intelligence on cash usage, lock-up activity, or management alignment. The absence of reported activity simply reflects standard Section 16 reporting protocol rather than a signal of deal fatigue or sponsorship shifts.
What changed: Quarterly report (Form 10-Q) for the period ended September 30, 2025, filed prior to the company's IPO (which closed on November 5, 2025). This is the first periodic filing since formation (June 3, 2025). The company had zero cash and a working capital deficit of $449,377 as of September 30, 2025. Deferred offering costs of $460,563 were capitalized. The IPO and private placement closed after quarter end on November 5, 2025, depositing $57.5 million ($10.00 per unit) into the trust account. The company also disclosed ineffective disclosure controls (material weakness). No deal target has been identified. Why it matters: This filing establishes the baseline pre-IPO financial position, confirms the trust per-share value of $10.00, the 18-month deadline ending May 5, 2027, sponsor founder share terms (including lock-up of 180 days post-business combination with early release conditions), and the $10.00 per-unit private placement terms. It also flags a material weakness in internal controls. For investors tracking redemption mechanics, the trust amount and deadline are now on record.
What changed: Form 12b-25 Notification of Late Filing for a delayed quarterly report. Per Chief Executive Officer Kok Peng Na, Westin Acquisition Corp could not timely submit its Form 10-Q for the quarter ended September 30, 2025, because the financial statements could not be finalized quickly enough to permit review and signature collection before the statutory deadline. The registrant states that all other periodic reports required under Sections 13 and 15(d) of the Securities Exchange Act of 1934 and Section 30 of the Investment Company Act of 1940 over the preceding twelve months have been filed, and management anticipates no significant change in results of operations for the upcoming report. The filing does not modify the announced business combination window, the liquidation deadline, redemption mechanics, or the existing trust account structure. Why it matters: Late-filing notifications are routine compliance exhibits, but in a pre-combination SPAC, reporting slippage reflects internal processing friction that executives and auditors must clear before merger execution. Because the registrant explicitly attributes the delay to signature and review sequencing rather than contested accounting positions, liquidity shortfalls, customer defaults, partnership disputes, or litigation, the immediate risk to capital preservation remains low. Nevertheless, failure to file within the five-calendar-day grace window mandated by Rule 12b-25 for quarterly reports can trigger SEC notices and exchange listing compliance reviews, which may indirectly pressure sponsor decision-making regarding extension votes or deal acceleration. No claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel changes are contained in the text.
What changed: Form 8-K current report announcing the consummation of an initial public offering and private placement, accompanied by an audited balance sheet and detailed notes as of November 5, 2025. The registrant's filing confirms the closing of Westin Acquisition Corp's IPO on November 5, 2025, with 5,750,000 units sold at $10.00 per unit following the full exercise of the underwriter's over-allotment option, generating $57,500,000 in gross proceeds. Simultaneously, the sponsor Westin Investment Co. Ltd. purchased 235,000 private placement units for $2,350,000. According to the company's statements, $57,500,000 was deposited into a trust account administered by Odyssey Transfer and Trust Company. The accompanying audited balance sheet reports a final trust balance of $57,500,005. Outside the trust, the company holds $642,372 in cash alongside a $449,377 related-party promissory note. Management sets the 18-month combination period to expire on May 5, 2027. On deal progress, the registrant states it has not selected a target and has not initiated substantive discussions with any prospective business combination candidate. The sponsor has contractually waived redemption and liquidation distribution rights for its Class B shares and private units. Why it matters: This filing locks in the definitive trust account value at $57,500,005, setting the precise starting point for all future per-share redemption math. The documented $2,300,000 deferred underwriting commission and the stipulated cap of up to $100,000 in interest usable for dissolution expenses define the fixed mechanical deductions from shareholder proceeds upon either a successful merger or liquidation. Management's explicit going concern determination highlights that failure to execute a transaction by May 5, 2027 triggers automatic winding up and dissolution, extinguishing public shareholder rights. Operationally, the company's agreement to pay a sponsor affiliate $10,000 per month in administrative support fees establishes a recurring liquidity drain, while the potential conversion of up to $1,500,000 in sponsor working capital loans into post-combination units at $10.00 per unit introduces a structured dilution pathway.
What changed: A Joint Filing Agreement attached as an exhibit to a Schedule 13G submission, executed by Feis Equities LLC and its Managing Member Lawrence M. Feis, consenting to file a combined disclosure for Class A ordinary shares of Westin Acquisition Corp dated as of November 10,2025 pursuant to Rule 13d-1(k) under the Securities Exchange Act of 1934. Feis Equities LLC and Lawrence M. Feis state in the agreement that they will submit the referenced Schedule 13G and any future amendments jointly on behalf of both entities. The text introduces no modifications to redemption deadlines, trust account valuations, extension mechanisms, business combination schedules, or sponsor conduct protocols. Why it matters: According to the document's language, the filing solely consolidates regulatory reporting obligations for the two signatories. It does not alter shareholder liquidity windows, trust preservation terms, or acquisition mechanics. Investors monitoring redemption timelines or sponsor behavior will find no operational shifts; the agreement merely satisfies joint disclosure requirements under the 1934 Act.
What changed: Form 8-K Current Report filed by Westin Acquisition Corp to report the consummation of its initial public offering (IPO), including the full exercise of the underwriters' over-allotment option, the private placement of units to the sponsor, the appointment of independent directors, and the adoption of amended charter documents. The company completed its IPO of 5,750,000 units at $10.00 per unit, generating $57,500,000 in gross proceeds, all of which (together with $2,350,000 from a private placement of 235,000 private units to the sponsor) was deposited into the trust account. The units began trading on Nasdaq on November 4, 2025. Three independent directors were appointed. The company's Amended and Restated Memorandum and Articles of Association became effective. The target business acquisition period runs 18 months from the IPO closing (i.e., until approximately May 5, 2027). Why it matters: This filing establishes the baseline trust value of approximately $10.00 per public share, sets the 18-month deadline for completing an initial business combination, and defines the sponsor's economics (including 25.93% ownership of Class B shares, subject to forfeiture adjustments). Investors can now track the trust balance, monitor extension votes, and evaluate future deal announcements against this baseline.
What changed: A final prospectus filed pursuant to Rule 424(b)(4) for the initial public offering of Westin Acquisition Corp, a blank-check SPAC incorporated in the Cayman Islands. It registers the offering of 5,000,000 units at $10.00 per unit. The filing presents the complete terms of the offering, the SPAC's structure, investment strategy, risk factors, trust mechanics, sponsor arrangements, and audited financial statements. This is the final prospectus for the IPO; no prior prospectus in the filing corpus for comparison. The document establishes the SPAC's baseline terms: trust at $10.00 per unit (100% of gross proceeds deposited), 18-month deadline from closing (May 5, 2027 per the metadata), unlimited extension votes with redemption rights, a 15% shareholder redemption cap during a shareholder vote, rights that are one-sixth of a share upon a business combination, underwriter over-allotment of 750,000 units, and sponsor purchase of 220,000 private units ($2.2 million). Sponsor held 2,012,500 Class B shares purchased for $25,000; up to 262,500 of those are forfeitable depending on over-allotment exercise. Net tangible book value (NTBV) per share after the offering (no over-allotment, no redemptions) is $6.13; implied value per share to public upon a business combination (no redemptions) is $6.661. Why it matters: This is the singular formative document for a new SPAC, setting all redemption deadlines, trust mechanics, sponsor economics, and extension terms. Investors tracking this vehicle for potential deal announcements will need these baseline terms to evaluate any future deal, amendment, or trust action. The low sponsor cost ($0.0124 per share) and the anti-dilution clause on the Class B shares create strong sponsor incentives to complete any deal, potentially a riskier one. The SPAC has a CFIUS risk and a blanket exclusion of Greater China targets, narrowing the target pool. There is no target identified and no substantive discussions have occurred.
What changed: Form 8-A12B for the registration of certain classes of securities under Section 12(b) of the Securities Exchange Act of 1934. Following this identification, the document reports that the Registrant has registered Units, Class A Ordinary Shares (par value $0.0001), and Rights (entitling holders to receive 1/6 of one Class A ordinary share) for listing on The Nasdaq Capital Market. Mechanically, the Registrant states that solely the Units will trade until the 52nd day following the date of the Company’s final prospectus, after which they may be separately traded subject to a Form 8-K and press release. No amendments affect the redemption calendar, trust account composition, extension mechanisms, proposed merger timing, or sponsor conduct. The filing was executed by Chief Executive Officer and Chairman Kok Peng Na on October 29, 2025, incorporating descriptions from a Registration Statement initially filed on July 23, 2025. Why it matters: Beyond these administrative mechanics, the Registrant makes no claims regarding customer concentration, revenue generation, total addressable market size, corporate strategy, underlying technology, strategic partnerships, active litigation, or management team alterations. For investors tracking redemption deadlines, trust value, and deal progression, this routine listing confirmation neither advances nor delays the scheduled timeline, nor does it provide new fundamental data points. Its materiality lies strictly in establishing the regulatory sequencing for unit decoupling and exchange participation, leaving all prior valuation, liquidation, and combination parameters intact.
What changed: Registration statement amendment (S-1/A, Amendment No. 3) for the initial public offering of a blank check company, including a preliminary prospectus dated October 10, 2025. This amendment includes updated audited financial statements as of June 30, 2025, and for the period from June 3, 2025 (inception) through June 30, 2025, along with a consent of the independent registered public accounting firm. It also updates the prospectus with final offering terms, including the $10.00 per unit price, $50 million trust account, 18-month deadline, sponsor compensation details, and dilution tables. The prospectus is now subject to completion. Why it matters: This filing provides the final financials and prospectus terms for investors evaluating the IPO. It confirms the trust account size ($10.00 per share), the redemption mechanics, the 18-month deadline (extendable with shareholder approval), and the sponsor's nominal cost for founder shares (approx. $0.0124 per share) and private placement ($2.2 million). It also discloses the SPAC will not target companies in Greater China and highlights significant sponsor conflicts of interest. The updated financial statements are a key input for assessing the SPAC's financial position before the offering.
What changed: This is a Securities and Exchange Commission correspondence filing (CORRESP) submitting legal counsel’s responses to staff comments from the Division of Corporation Finance’s Office of Life Sciences regarding Westin Acquisition Corp.’s Amended Registration Statement on Form S-1. In response to SEC Staff feedback dated August 29, 2025, counsel Cassi Olson confirmed that the prospectus summary was revised to highlight the firm’s dual-class capital structure. Specifically, disclosure on pages 11, 45, and 116 now emphasizes that ‘only Class B shareholders will have the right to vote to appoint and remove directors prior to, or in connection with, the completion of your initial business combination’ and that only Class B holders will vote on continuing the entity in a jurisdiction outside the Cayman Islands. No modifications to redemption procedures, trust account mechanics, extension provisions, or announced deal progress were reported in this submission. Why it matters: The revision directly informs investors tracking post-IPO governance and pre-deal control: public shareholders lack director appointment/removal authority until the merger closes, concentrating interim board control solely with Class B holders. Because the document contains zero assertions regarding target customers, revenue streams, market positioning, technological capabilities, strategic partnerships, ongoing litigation, or executive personnel changes, it carries no new commercial or financial substance. It remains a routine regulatory compliance exhibit that clarifies voting hierarchy without shifting the redemption calendar or trust preservation terms ahead of the business combination timeline.
What changed: Amendment No. 2 to a Registration Statement on Form S-1 (S-1/A) filed by a blank-check company, Westin Acquisition Corp, to register its initial public offering of 5,000,000 units at $10.00 per unit, each unit consisting of one Class A ordinary share and one right to receive one-sixth of one Class A ordinary share, along with the over-allotment option and private placement units. This is the underwritten IPO registration for a new SPAC, Westin Acquisition Corp. The filing states the trust will hold $10.00 per unit ($50,000,000, or up to $57.5 million with the overallotment). The company has 18 months from the closing of the offering to complete a business combination. It may seek shareholder approval to extend this period. Public shareholders will have the right to redeem their shares for a pro rata share of the trust upon a business combination. The sponsor, Westin Investment Co. Ltd., purchased 2,012,500 Class B shares for $25,000 ($0.0124/share) and will purchase 220,000 private units at $10.00 each. The company will not pursue a target with the majority of its operations in Greater China. Why it matters: This filing provides the definitive terms for the SPAC's IPO. The $10.00 trust value and 18-month deadline are the key redemption and timeline mechanics. The small founder stake ($25,000 for roughly 28% of the post-IPO shares) creates a significant conflict of interest: the sponsor is highly incentivized to close any deal, even a poor one, to avoid their shares becoming worthless. The prohibition on Greater China targets narrows the search universe.
What changed: SEC Division of Corporation Finance Office of Life Sciences comment letter dated August 29, 2025 addressing Amendment No. 1 to Registration Statement on Form S-1 (File No. 333-288889). The SEC staff reissued Comment 2, observing that the prospectus currently states only Class B shareholders may vote to appoint or remove directors before or during the initial business combination, and exclusively those shareholders may vote on continuing operations outside the Cayman Islands. The staff requested a revision to the Prospectus Summary to explicitly highlight the dual-class capital structure and the disparate voting rights attached to Class A and Class B ordinary shares. Why it matters: First, this is a regulatory disclosure comment letter rather than a merger agreement, resignation, interview transcript, routine compliance exhibit, investor presentation, or lawsuit. Second, regarding tracked mechanics: the filing does not change the May 5, 2027 redemption timeline, shift trust distribution mechanics, alter extension provisions, update deal progress following the announced target phase, or reflect sponsor conduct adjustments attributed to corporate leadership. Third, the document contains no substantiated commercial or operational claims; it does not cite customer concentrations, historical revenue lines, market sizing data, technology specifications, partnership agreements, active litigation posture, or executive succession plans. The SEC explicitly noted it may issue additional comments after reviewing the required prospectus amendment, making this a procedural housekeeping step rather than a substantive transaction modification.
What changed: Amendment No. 1 to a Registration Statement on Form S-1 (S-1/A) for a proposed initial public offering of a blank check company (SPAC). This is an amendment to the registration statement first filed on Form S-1. The filing is a preliminary prospectus. There is no disclosure of changes from the prior filing; the document appears to be a complete, updated version of the prospectus. The filing does not contain any new terms related to a specific deal, trust value, or redemption mechanics beyond what is already set forth in the standard SPAC structure. The document states the SPAC has not selected any business combination target and has not initiated any substantive discussions with any target. Why it matters: The filing is a standard update to the registration statement for a new SPAC IPO. It confirms the SPAC is still in its pre-deal formation stage. For investors, the key takeaway is that the trust is $10.00 per unit, the deadline is 18 months from the closing of the offering, and the sponsor has made a nominal investment. The document provides a detailed risk factor section and a breakdown of sponsor compensation and potential conflicts of interest. There is no new information about a pending business combination, any material changes to the redemption mechanics, or any sponsor conduct concerns.
What changed: A submission response letter from Westin Acquisition Corp’s legal counsel to the SEC Division of Corporation Finance, reacting to a comment letter dated August 19, 2025 regarding the company’s July 23, 2025 Form S-1 registration statement. Regarding deal mechanics and shareholder rights, the SEC Division of Corporation Finance staff commented that the prospectus needed to confirm whether Nasdaq approval governed closing, detail extension limitations under Regulation S-K Item 1602(b)(4), reconcile redemption meeting notice periods with Exchange Act Rule 14a-6(q), standardize dilution calculations regarding 833,334 public shares underlying public rights, and verify management’s prior SPAC history. According to Cassi Olson signing for Westin’s counsel, the company revised the registration statement to state that Nasdaq approval will condition closing, that extension limits will be explicitly disclosed, that general meeting notices will align with Rule 14a-6(q) dissemination windows, that the rights inclusion/exclusion methodology will be standardized, and that no officer or director has participated in any other SPACs or business combinations. The counsel further advised that Class A and Class B ordinary shares carry identical voting rights and that redemption procedures will comply with SEC dissemination standards. Why it matters: Beyond mechanics, the SEC staff questioned claims of biotechnology experience, demanded identification of sponsor-priority entities, flagged a missing risk factor title, and asked why Greater China risk disclosures applied when the company excluded those targets and maintained Singaporean and Malaysian residency for all executives. Per the counsel’s responses, Westin removed biotechnology references, agreed to name all entities holding priority or preference interests, corrected the risk factor cross-reference, and will explain the jurisdictional rationale despite excluding Greater China-domiciled companies. These adjustments materially inform the redemption calculus and sponsor conduct assessment ahead of the 2027-05-05 deadline by eliminating ambiguous sector positioning, exposing potential conflict-of-interest waterfalls, verifying a clean SPAC leadership track record, and narrowing the permissible target universe. Because the filing reflects only regulatory compliance corrections to an unapproved registration statement, no target acquisition, cash conversion, or trust deployment has occurred, and all mechanical disclosures remain provisional pending final prospectus certification and Nasdaq listing clearance.
What changed: SEC Division of Corporation Finance Office of Life Sciences comment letter dated August 19, 2025, directed to Kok Peng Na, Chief Executive Officer of Westin Acquisition Corp, regarding the company’s Registration Statement on Form S-1 filed July 23, 2025 (File No. 333-288889). The filing does not execute a transaction or amend terms but issues ten regulatory directives requiring the registrant to revise its disclosure. Mechanics-bearing requests identified by the SEC staff include: confirming whether offering closing is contingent upon Nasdaq approval of the listing application; expanding disclosure on any limitations regarding the number of times the company may seek shareholder approval to extend the date to consummate its initial business combination; reconciling the charter’s five-day general meeting notice period with Exchange Act Rule 14a-6(q) minimum dissemination requirements; clarifying dilution calculations around publicly exercisable rights and consistently stating whether those rights are included or excluded, specifically referencing the assumption of 833,334 public shares underlying public rights in footnote four; and mandating transparent reporting of sponsor conduct by disclosing any prior SPACs or business combinations involving management, including associated extension terms, redemption levels during those extensions, and current trading prices for completed de-SPAC transactions, per Regulation S-K Item 1603(a)(3). Why it matters: Resolving these comments dictates the path to prospectus effectiveness and influences investor positioning relative to the stated 2027-05-05 deadline. Clarified extension caps and redemption notice windows directly affect redemption calendar planning and trust value preservation. Mandatory disclosure of prior SPAC histories and redemption outcomes provides a baseline for evaluating sponsor capital discipline and operational conduct before capital commitments deepen. Substantively, the SEC staff questions the registrant’s strategic alignment, challenging the basis for claims that management possesses significant experience in biotechnology and flagging a material drafting contradiction: the prospectus repeatedly warns of risks tied to China-based investments despite the summary asserting no Greater China operations or target focus, even though officers and directors are Singapore and Malaysia residents with no apparent China ties. The staff also notes the absence of a cross-referenced risk factor titled “Since our sponsor, officers and directors, any other holder of our initial shares may lose their entire investment in us if our initial business combination is not completed...” and requests identification of entities holding priority and preference rights over directors’ and officers’ other affiliated interests. All assertions, figures, and regulatory references originate from the written review conducted by the SEC Division of Corporation Finance, Office of Life Sciences, and were transmitted via correspondence to designated division contacts (Bonnie Baynes, Daniel Gordon, Tyler Howes, Chris Edwards) with copies to Cassi Olson, Esq.
What changed: Initial registration statement on Form S-1 for the proposed initial public offering of Westin Acquisition Corp, a blank check company (SPAC) formed to effect a merger or acquisition. The S-1 is a preliminary prospectus that sets forth the terms of the IPO, the company's structure, risk factors, use of proceeds, and provisions for its future business combination. This is the first registration statement filed by Westin Acquisition Corp. There are no prior filings to compare. The document establishes all key terms: 5,000,000 units offered at $10.00 per unit (plus an over-allotment option of up to 750,000 units); each unit consists of one Class A ordinary share and one right to receive one-sixth of one Class A ordinary share upon a business combination; $50,000,000 ($10.00 per unit) will be placed in a U.S.-based trust account; the company has 18 months from the closing of the IPO to complete an initial business combination; public shareholders have redemption rights upon completion of a business combination; and the sponsor (Westin Investment Co. Ltd.) holds 2,012,500 Class B ordinary shares (up to 262,500 subject to forfeiture) and will purchase 220,000 private units ($2,200,000) in a private placement. Why it matters: The S-1 provides the foundational terms for the SPAC IPO that investors will use to evaluate the security. Key details include the trust amount ($10.00 per share), redemption mechanics, the 18-month deadline to complete a deal, sponsor economics (nominal cost for founder shares creating dilution risk), and the scope of search (global but excluding companies with majority operations in Greater China). The filing also discloses significant conflicts of interest and sponsor incentives that could affect deal terms. For investors tracking redemption deadlines, trust value maintenance, extensions, and sponsor conduct, this document sets all baseline parameters.
In plain English
Redemption deadlinethe last day to hand shares back for cash
Set by the filing that calls the meeting. Tender after it and the company is under no obligation to pay you the trust value.
Cash in trust / trust per sharethe cash the company is holding for each public share
Filed quarterly in the 10-Q's XBRL. It earns interest between filings, so the figure on a given day is slightly higher than the last filed one — where we show that we label it an estimate.
Accession numberthe SEC's unique id for one filing
Every figure on this page carries the accession of the filing that states it, so you can open the primary document rather than trust us.